Table 2 |
|||||||
|
TERC and C-MYC positivity rates for various histological diagnoses |
|||||||
|
Histological diagnosis |
Case no. |
TERC positive |
C-MYC positive |
||||
|
|
|||||||
|
Case no. |
% |
P |
Case no. |
% |
P |
||
|
|
|||||||
|
Normal |
164 |
15 |
9.2 |
34 |
20.7 |
||
|
CIN1† |
29 |
5 |
17.2 |
9 |
31.0 |
||
|
CIN2 |
21 |
16 |
76.2 |
15 |
71.4 |
||
|
CIN3 |
22 |
22 |
100.0 |
18 |
81.8 |
||
|
SCC |
7 |
7 |
100.0 |
7 |
100.0 |
||
|
Normal vs. CIN1 |
> 0.05 |
> 0.05 |
|||||
|
CIN1 vs. CIN2+ |
< 0.01* |
< 0.01* |
|||||
|
Normal/CIN1 vs. CIN2+ |
< 0.01* |
< 0.01* |
|||||
|
|
|||||||
|
† CIN1 includes lesions previously classified as mild dysplasia, koilocytotic atypia, koilocytosis and flat condyloma * P < 0.05: statistically significant difference between 2 categories |
|||||||
|
Chen et al. Diagnostic Pathology 2012 7:40 doi:10.1186/1746-1596-7-40 |
|||||||